<DOC>
	<DOCNO>NCT00368498</DOCNO>
	<brief_summary>The purpose study determine whether standard dosage teicoplanin adequate produce timely trough level &gt; 10 mg/L , consider effective treatment methicillin-resistant Staphyllococcus aureus ( MRSA ) bacteremia .</brief_summary>
	<brief_title>A Trial Evaluate Loading Dose Required Achieve Therapeutic Serum Teicoplanin Concentration Timely</brief_title>
	<detailed_description>In hospital , minimum inhibitory concentration 100 MRSA isolates 2003 teicoplanin 2 mg/L . Due time-dependant bacteriocidal effect , trough level exceed 10 mg/L , particularly elderly , MRSA bacteremia . However , know standard dosage teicoplanin often produce inadequate serum trough level , MRSA infection may recur . Therefore , evaluate load dose require achieve therapeutic concentration timely , compare trough level give standard dose ( 6 mg/Kg ) give increase load dose ( 12 mg/Kg ) . We also monitor occurrence adverse drug effect clinical response .</detailed_description>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Teicoplanin</mesh_term>
	<criteria>Patients 16 year age blood cultureproven MRSA bacteremia receive teicoplanin vancomycin previous one month enrol . Those allergic teicoplanin need use high dos , 12 mg/kg/dose , endocarditis , osteomyelitis , septic arthritis burn patient , exclude .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>teicoplanin</keyword>
</DOC>